According to reports, Alexion Pharmaceuticals, Inc. (ALXN) announced today that a Phase 2 clinical study investigating Soliris(R) (eculizumab) as a treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) who are resistant to plasma therapy met primary and key secondary endpoints with high levels of statistical and clinical significance, according...
With all of the money backing the necessary bailouts of the EuroZone banks and governments, it looks as if there is little more than continuing fear that has investors pulling money out of related investments.
Even with a $1 trillion or so backstop, the number keep growing on just how much...
Guest: Terry Bedford, GreyHawk Hedge Fund and writer for thestreet.com discusses his strategy. Now that the S&P 500 has shot past 1,175, what next? When do you get short, when do you push the longs. Terry provides insight as well as some of his favorite stock ideas.
Read More
The Bernanke and The Fed, The Printing Money and The Recession. Raising prices to benefit consumers..??
Hysterical…
After the scare we had earlier in the week, it looks like no one even recalls that Austria is balking at paying anymore to backstop Greece. Now that England is willing to reach deep to help out Ireland and there is talks of a bailout approaching $100 billion. WOW!
In the...
